B-cell receptor signaling in chronic lymphocytic leukemia leans on Lyn

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Leukemia and Lymphoma

• Publication date

  2013-01-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/10428194.2012.754097PMID 23270582
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression levels of Lyn, Syk, PLCγ2 and ERK in patients with chronic lymphocytic leukemia, and higher levels of Lyn are associated with a shorter treatment-free survival

  2013cited by this paper
• The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo.

  2012cited by this paper
• Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

  2011cited by this paper
• Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia.

  2010cited by this paper
• Stereotypical Chronic Lymphocytic Leukemia B-Cell Receptors Recognize Survival Promoting Antigens on Stromal Cells

  2010cited by this paper
• Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy.

  2008cited by this paper
• ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia.

  2008cited by this paper
• Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.

  2008cited by this paper
• Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.

  2006cited by this paper
• Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis.

  2005influential reference
• Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.

  2005cited by this paper
• Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins.

  2004cited by this paper
• Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia

  2004cited by this paper
• von Willebrand factor cleavage ADAMTS-13 cysteine-rich / spacer domains are functionally essential for

  2003cited by this paper
• Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.

  2003cited by this paper
• ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.

  2003cited by this paper
• ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

  2003cited by this paper
• Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia.

  2002cited by this paper
• Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells

  2001cited by this paper
• Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia

  2001cited by this paper
• Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

  1999cited by this paper
• Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

  1999cited by this paper

• Chapter 9 Chronic Lymphocytic Leukemia — Microenvironment and B Cells

  2017influential citation
• Chronic Lymphocytic Leukemia — Microenvironment and B Cells

  2015influential citation
• Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients

  2014cites this paper
• “Role of the B-cell receptor and the microenvironment in chronic lymphocytic leukemia''

  2013cites this paper